chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity, Pyrexia, Vaccination site haemorrhage
Clinical narrative: Bleeding when I had the injection; Right arm hurts; Not feeling good; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bleeding when I had the injection), PAIN IN EXTREMITY (Right arm hurts), MALAISE (Not feeling good) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HAEMORRHAGE (Bleeding when I had the injection), PAIN IN EXTREMITY (Right arm hurts), MALAISE (Not feeling good) and PYREXIA (Fever). At the time of the report, VACCINATION SITE HAEMORRHAGE (Bleeding when I had the injection), PAIN IN EXTREMITY (Right arm hurts), MALAISE (Not feeling good) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vials that had exceeded the 30 day refrigeration limit; Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) and PRODUCT STORAGE ERROR (Vials that had exceeded the 30 day refrigeration limit) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials that had exceeded the 30 day refrigeration limit). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) and PRODUCT STORAGE ERROR (Vials that had exceeded the 30 day refrigeration limit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that patient had pain in the arm and is bothering her for about 3 months no.  No concomitant medication was reported  No treatment medication was reported
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling on the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling on the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling on the arm). At the time of the report, PERIPHERAL SWELLING (Swelling on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Heart rate, Nasopharyngitis, Oropharyngeal pain
Clinical narrative: cold like symptoms; sore throat; coughing; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat) and COUGH (coughing) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LATANOPROST for an unknown indication.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat) and COUGH (coughing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat) and COUGH (coughing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-May-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Respiratory rate decreased
Clinical narrative: Slower breathing patterns; Swollen lymph node in my neck; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY RATE DECREASED (Slower breathing patterns) and LYMPHADENOPATHY (Swollen lymph node in my neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced RESPIRATORY RATE DECREASED (Slower breathing patterns) and LYMPHADENOPATHY (Swollen lymph node in my neck). At the time of the report, RESPIRATORY RATE DECREASED (Slower breathing patterns) and LYMPHADENOPATHY (Swollen lymph node in my neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided.   Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved.            Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I got the moderna 2nd shot last friday and im starting to feel more side effects now (5 days after getting the shot) is this normal?; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I got the moderna 2nd shot last friday and im starting to feel more side effects now (5 days after getting the shot) is this normal?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I got the moderna 2nd shot last friday and im starting to feel more side effects now (5 days after getting the shot) is this normal?). At the time of the report, VACCINATION COMPLICATION (I got the moderna 2nd shot last friday and im starting to feel more side effects now (5 days after getting the shot) is this normal?) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.   Reporter did not allow further contact
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Insomnia, Somnolence, Vaccination site pain
Clinical narrative: feeling weak; groggy; site of injection, were very sore.; had difficulty sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (had difficulty sleeping), ASTHENIA (feeling weak), SOMNOLENCE (groggy) and VACCINATION SITE PAIN (site of injection, were very sore.) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced INSOMNIA (had difficulty sleeping) and VACCINATION SITE PAIN (site of injection, were very sore.). On 27-May-2021, the patient experienced ASTHENIA (feeling weak) and SOMNOLENCE (groggy). At the time of the report, INSOMNIA (had difficulty sleeping), ASTHENIA (feeling weak), SOMNOLENCE (groggy) and VACCINATION SITE PAIN (site of injection, were very sore.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: possible administration of 2nd dose outside of the dosing interval of 42 days; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received the first dose of the Moderna COVID-19 Vaccine back in March. No Concomitant  information was  provided. No Treatment information was  provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Dizziness, Hypoaesthesia
Clinical narrative: Felt arms asleep; Felling dizzy; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Felt arms asleep) and DIZZINESS (Felling dizzy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, Hematuria and Cyst of kidney.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HYPOAESTHESIA (Felt arms asleep) and DIZZINESS (Felling dizzy). On 11-Mar-2021, DIZZINESS (Felling dizzy) had resolved. At the time of the report, HYPOAESTHESIA (Felt arms asleep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Blood pressure decreased: (Inconclusive) Blood pressure decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient historical condition includes Infundibulum cerebral. No Concomitant  information was  provided. No Treatment information was  provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Feeling abnormal, Muscle twitching, Nausea
Clinical narrative: Foggy; right arm has been twitching; Itching at the injection site; Redness at the injection site; swelling at the injection site; Blotchy at injection site; Couldn't stay awake; Confused; Had no energy; feverish; Nauseous; Eperienced a sore arm for 1-2 days which was worse the second night, tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy) and FEELING ABNORMAL (Foggy) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness). On 23-May-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), PYREXIA (feverish) and NAUSEA (Nauseous). On 27-May-2021, the patient experienced MUSCLE TWITCHING (right arm has been twitching). On an unknown date, the patient experienced FEELING ABNORMAL (Foggy). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 26-May-2021, SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness), PYREXIA (feverish) and NAUSEA (Nauseous) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (Blotchy at injection site), MUSCLE TWITCHING (right arm has been twitching) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved and FEELING ABNORMAL (Foggy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient slept, and used cold packs on her head and arm for her symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence, Vaccination site discolouration, Vaccination site erythema, Vaccination site pain
Clinical narrative: Foggy; right arm has been twitching; Itching at the injection site; Redness at the injection site; swelling at the injection site; Blotchy at injection site; Couldn't stay awake; Confused; Had no energy; feverish; Nauseous; Eperienced a sore arm for 1-2 days which was worse the second night, tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy) and FEELING ABNORMAL (Foggy) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness). On 23-May-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), PYREXIA (feverish) and NAUSEA (Nauseous). On 27-May-2021, the patient experienced MUSCLE TWITCHING (right arm has been twitching). On an unknown date, the patient experienced FEELING ABNORMAL (Foggy). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 26-May-2021, SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness), PYREXIA (feverish) and NAUSEA (Nauseous) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (Blotchy at injection site), MUSCLE TWITCHING (right arm has been twitching) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved and FEELING ABNORMAL (Foggy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient slept, and used cold packs on her head and arm for her symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Foggy; right arm has been twitching; Itching at the injection site; Redness at the injection site; swelling at the injection site; Blotchy at injection site; Couldn't stay awake; Confused; Had no energy; feverish; Nauseous; Eperienced a sore arm for 1-2 days which was worse the second night, tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy) and FEELING ABNORMAL (Foggy) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness). On 23-May-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Blotchy at injection site), SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), PYREXIA (feverish) and NAUSEA (Nauseous). On 27-May-2021, the patient experienced MUSCLE TWITCHING (right arm has been twitching). On an unknown date, the patient experienced FEELING ABNORMAL (Foggy). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 26-May-2021, SOMNOLENCE (Couldn't stay awake), CONFUSIONAL STATE (Confused), ASTHENIA (Had no energy), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (Eperienced a sore arm for 1-2 days which was worse the second night, tenderness), PYREXIA (feverish) and NAUSEA (Nauseous) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (Blotchy at injection site), MUSCLE TWITCHING (right arm has been twitching) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved and FEELING ABNORMAL (Foggy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient slept, and used cold packs on her head and arm for her symptoms.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Sinusitis
Clinical narrative: sinus infection; heart palpitations; This spontaneous case was reported by a pharmacist and describes the occurrence of SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations). At the time of the report, SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history not provided. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: TCR follow up received on June 9th.  Reporter stated that patient never received the vaccine.
Age: 50.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: second dose not administered past 42 days; diagnosed with Covid 19 infection; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose not administered past 42 days) and COVID-19 (diagnosed with Covid 19 infection) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was reported.     On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced COVID-19 (diagnosed with Covid 19 infection). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose not administered past 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (second dose not administered past 42 days) and COVID-19 (diagnosed with Covid 19 infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm still very sore / suffering severe arm pain 3 months after my shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm still very sore / suffering severe arm pain 3 months after my shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm still very sore / suffering severe arm pain 3 months after my shot). At the time of the report, PAIN IN EXTREMITY (arm still very sore / suffering severe arm pain 3 months after my shot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.    Reporter did not allow further contact
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: had received doses from vials that had exceeded the 30 day refrigeration limit/  Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (had received doses from vials that had exceeded the 30 day refrigeration limit/  Received Expired Dose of Vaccine) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (had received doses from vials that had exceeded the 30 day refrigeration limit/  Received Expired Dose of Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (had received doses from vials that had exceeded the 30 day refrigeration limit/  Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Pain, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: and hurts from time to time; started to swell, like a ball; extended to the neck; inflamed; itchy; left arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm felt sore), PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed) and PRURITUS (itchy) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced PAIN IN EXTREMITY (left arm felt sore). On 19-May-2021, the patient experienced PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed) and PRURITUS (itchy). On an unknown date, the patient experienced PAIN (and hurts from time to time). At the time of the report, PAIN IN EXTREMITY (left arm felt sore), PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed), PRURITUS (itchy) and PAIN (and hurts from time to time) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: and hurts from time to time; started to swell, like a ball; extended to the neck; inflamed; itchy; left arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm felt sore), PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed) and PRURITUS (itchy) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced PAIN IN EXTREMITY (left arm felt sore). On 19-May-2021, the patient experienced PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed) and PRURITUS (itchy). On an unknown date, the patient experienced PAIN (and hurts from time to time). At the time of the report, PAIN IN EXTREMITY (left arm felt sore), PERIPHERAL SWELLING (started to swell, like a ball), SWELLING (extended to the neck), INFLAMMATION (inflamed), PRURITUS (itchy) and PAIN (and hurts from time to time) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Sinus congestion
Clinical narrative: Sore Throat; Sinus Congestion; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) and SINUS CONGESTION (Sinus Congestion) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     The patient's past medical history included Stem cell transplant in 2004 and Back surgery in January 2021. Concurrent medical conditions included Seasonal allergy. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Seasonal allergy.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and SINUS CONGESTION (Sinus Congestion). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) and SINUS CONGESTION (Sinus Congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She reported having allergy symptoms every spring and fall. Treatment information was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: the arm where the vaccine was given turned more red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (the arm where the vaccine was given turned more red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (the arm where the vaccine was given turned more red). At the time of the report, VACCINATION SITE ERYTHEMA (the arm where the vaccine was given turned more red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: fatigue; aching; arm ai injection site swelled; arm ai injection site turned red; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (aching), VACCINATION SITE SWELLING (arm ai injection site swelled), VACCINATION SITE ERYTHEMA (arm ai injection site turned red) and PYREXIA (low grade fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 20-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced VACCINATION SITE SWELLING (arm ai injection site swelled), VACCINATION SITE ERYTHEMA (arm ai injection site turned red) and PYREXIA (low grade fever). On an unknown date, the patient experienced FATIGUE (fatigue) and MYALGIA (aching). At the time of the report, FATIGUE (fatigue), MYALGIA (aching), VACCINATION SITE SWELLING (arm ai injection site swelled), VACCINATION SITE ERYTHEMA (arm ai injection site turned red) and PYREXIA (low grade fever) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: I have a fever of 102.5 degrees; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I have a fever of 102.5 degrees) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have a fever of 102.5 degrees). At the time of the report, PYREXIA (I have a fever of 102.5 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.5 c (High) 102.5 C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant drugs were provided.  No Treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Somnolence
Clinical narrative: Fell asleep for over 4 hours and could not wake up; Crushing headache; Bad fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Fell asleep for over 4 hours and could not wake up), HEADACHE (Crushing headache) and FATIGUE (Bad fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Fell asleep for over 4 hours and could not wake up). an unknown date, the patient experienced HEADACHE (Crushing headache) and FATIGUE (Bad fatigue). At the time of the report, SOMNOLENCE (Fell asleep for over 4 hours and could not wake up), HEADACHE (Crushing headache) and FATIGUE (Bad fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Urinary tract infection
Clinical narrative: Severe abdominal pain in area of his kidney disease; diagnosed with urinary tract infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN (Severe abdominal pain in area of his kidney disease) and URINARY TRACT INFECTION (diagnosed with urinary tract infection) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Polycystic kidney (polycystic kidney disease at stage three). Concomitant products included ALLOPURINOL, LOSARTAN, DILTIAZEM, ROSUVASTATIN and VITAMIN D3 for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced ABDOMINAL PAIN (Severe abdominal pain in area of his kidney disease) and URINARY TRACT INFECTION (diagnosed with urinary tract infection). On 14-Apr-2021, ABDOMINAL PAIN (Severe abdominal pain in area of his kidney disease) had resolved. At the time of the report, URINARY TRACT INFECTION (diagnosed with urinary tract infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Urinary tract infection: positive (Positive) diagnosed with urinary tract infection.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications provided was polycystic kidney disease meds.  Treatment medications provided was Intravenous antibiotics, Oral antibiotics, Pick line of antibiotics. Nephrologist advised stopping the oral antibiotic on 15 APR 2021 and everything appeared fine.  Patient undergone with the CT scan and Blood work.   This case was linked to MOD-2021-181828 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up received. Patient demographics added. Concomitant products were added. Event outcome for abdominal pain updated. Inconclusive lab results were removed from patient tab and coded in iNarrative supplement.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Myalgia
Clinical narrative: I'm sick now; Major headache; Body aches; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash (all over the body); This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash (all over the body)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history was provided by the Reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash (all over the body)). At the time of the report, RASH (rash (all over the body)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant  information was provided by the reporter. No Treatment information was provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Covid arm; Covid arm; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Covid arm), VACCINATION SITE ERYTHEMA (Covid arm) and VACCINATION SITE PRURITUS (Covid arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic fatigue in 2014 and Chronic pain in 2014. Concomitant products included LISINOPRIL, AMLODIPINE, RAMIPRIL, DENOSUMAB (PROLIA), CALCIUM, FISH OIL, BIOTIN, VITAMIN C [ASCORBIC ACID], CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), ALPHA LIPOIC ACID, UBIDECARENONE (COQ10 [UBIDECARENONE]), PYRIDOXINE HYDROCHLORIDE (B6), CINNAMOMUM CASSIA (CINNAMON [CINNAMOMUM CASSIA]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE RASH (Covid arm), VACCINATION SITE ERYTHEMA (Covid arm) and VACCINATION SITE PRURITUS (Covid arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Covid arm), VACCINATION SITE ERYTHEMA (Covid arm) and VACCINATION SITE PRURITUS (Covid arm) had resolved.            Treatment also included itch cream.  Both moderna vaccine and prolia injection was given in left arm.   This case was linked to MOD-2021-181863 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Additional information received: Updated past medical history and concomitant medications.; Sender's Comments: Based on the current available information and strong temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported event are consistent with the product safety profile.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: dizziness; Nausea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness) and NAUSEA (Nausea). At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nausea) outcome was unknown.            No concomitant medications were reported.  No treatment was reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal, Somnolence
Clinical narrative: has no energy; every 4 hours needs to sleep/cannot keep awake; he is in a daze; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (has no energy), SOMNOLENCE (every 4 hours needs to sleep/cannot keep awake), FEELING ABNORMAL (he is in a daze) and FATIGUE (fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ASTHENIA (has no energy), SOMNOLENCE (every 4 hours needs to sleep/cannot keep awake), FEELING ABNORMAL (he is in a daze) and FATIGUE (fatigue). At the time of the report, ASTHENIA (has no energy), SOMNOLENCE (every 4 hours needs to sleep/cannot keep awake), FEELING ABNORMAL (he is in a daze) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 24-May-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information does not provided by the reporter. No treatment information is provided by the reporter.